Trial intelligence / Profile preview

Donepezil for Memory Preservation Post-ECT

NCT02331771Terminated

Sponsor
Porter Adventist Hospital
Start
Sep 2015
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Memory impairment comparing Donepezil with Placebo (2 arms). Primary endpoint: Columbia University Autobiographical Memory Interview-Short Form. Started Sep 2015; status: terminated.

02

Drugs

donepezil
03

Conditions

Memory impairment

Beyond the preview

Go deeper on NCT02331771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02331771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call